TIMOTHY SO: Open Payments
NPI 1811901960 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 67 payments from 18 companies in 2025. Trend: 2023 $1,137 · 2024 $1,701 · 2025 $1,292
Food & beverage: $1,292
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $216 |
| Amgen Inc. | 14 | $203 |
| ABBVIE INC. | 11 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $101 |
| Janssen Pharmaceuticals, Inc | 3 | $100 |
| Neurocrine BioSciences, Inc. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| Novo Nordisk Inc | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $39 |
Products named: FANAPT, OTEZLA, VRAYLAR, Kerendia, INVEGA SUSTENNA, INGREZZA, TRELEGY ELLIPTA, ARISTADA.
Industry payments across CA — which companies pay providers there.
